论文部分内容阅读
目的观察得力生注射液联合GP方案化疗治疗晚期肺癌的疗效。方法将121例晚期非小细胞肺癌患者随机分成得力生注射液加化疗组和单纯化疗组。观察有效率、毒副作用及生活质量。结果得力生注射液加化疗组有效率为59%,单纯化疗组为31.7%。两组比较有显著性差异(P<0.05)。结论得力生注射液联合化疗治疗晚期非小细胞肺癌能提高治疗有效率,减轻化疗毒副作用,提高患者生活质量。
Objective To observe the efficacy of Delisheng injection combined with GP regimen in the treatment of advanced lung cancer. Methods A total of 121 patients with advanced non-small cell lung cancer were randomly divided into two groups: the injection of Tertiary injection plus chemotherapy and the chemotherapy alone. Observe the efficiency, side effects and quality of life. Results Delisheng injection plus chemotherapy group was 59%, chemotherapy alone group was 31.7%. There was significant difference between the two groups (P <0.05). Conclusion Tellus injection combined with chemotherapy for advanced non-small cell lung cancer can improve the treatment efficiency, reduce the side effects of chemotherapy and improve the quality of life of patients.